Podcasts about low dose

I'm reposting episodes that were taken down from Spotify. This is a repost of the 2023 conversation. Keith sits down with Itarya Rosenberg to discuss growing up in Bucks County, discovering the local scene, our early show-going experiences, navigating depression and institutions in his high school years and Itarya's early work in Legendary Divorce. We also discuss the formation of Low Dose, the band's history, the end of Low Dose and the beginning of Rid of Me, the band's history, their latest LP "Access to the Lonely", addiction, alcoholism, mental health and more.  Artist Spotlight: Keith speaks to Tristan D'Graves from Incendiary Device about their new self titled LP on Bridge Nine Records  Intro: 0:00 - 6:39 Rid of Me Interview: 6:40 - 1:00:37 Incendiary Device Interview: 1:00:50 - 1:24:11 Outro:  1:24:25 - 1:29:08

In this video, I share my personal experience with low-dose radiation therapy for osteoarthritis and inflammatory knee pain — a treatment with a long history in Europe that's now being re-examined in the U.S. as a safe, evidence-based option for chronic orthopedic pain. Low-dose radiation therapy (LDRT) involves the use of very small, precisely targeted doses of radiation — typically one-tenth or less of what's used in cancer treatment — to reduce inflammation and modulate immune response in joints, tendons, and soft tissues. Research has shown that these low doses can help relieve pain and improve mobility, often providing durable results without the side effects of steroids or long-term medications. I'm joined by Dr. Sanjay Mehta, Radiation Oncologist at St. Joseph Cancer Center in Houston, to discuss the science behind this therapy, its mechanisms of action, and the clinical outcomes we're seeing today for conditions such as: • Osteoarthritis • inflammatory knee pain • Plantar fasciitis • Tennis elbow • Shoulder and joint pain You'll also see a glimpse of my own treatment session, as we explore how this “old yet new” approach is helping patients regain comfort, function, and quality of life — without medications or surgery. Resources: Dr. Sanjay Mehta, Radiation Oncologist St. Joseph Cancer Center https://drsanjaymehta.com/

Today's episode is one I've really been looking forward to because we're diving into something that's transforming the way we think about mental health treatment: low-dose ketamine therapy. My guest, Dr. Sharon Niv, is the co-founder of Joyous, a public benefit company helping make this kind of care more accessible and affordable than ever before. Sharon brings a fascinating background in cognitive psychology, meditation, and technology, and she's helping bridge the gap between neuroscience and therapy in a way that's incredibly gentle, safe, and empowering for both clients and clinicians. We'll talk about what makes psycholytic, or low-dose, ketamine different from traditional psychedelic experiences, how it can enhance the therapeutic process, and how you, as a therapist, can get trained to integrate it into your own work. This is one of those conversations that opens your mind to what's possible in therapy, so let's jump in. Resources Mentioned In This Episode Use the promo code "GORDON" to get 2 months of Therapy Notes free Consulting with Gordon The PsychCraft Network Profit First for Therapists Workbook Meet Sharon Niv, Ph.D. Dr. Sharon Niv is a cognitive psychologist and co-founder of Joyous Team, a Public Benefit Corporation dedicated to making evidence-based mental health treatments accessible and affordable. Her work bridges the worlds of neuroscience, technology, and therapy with a focus on how scalable, data-driven approaches can enhance emotional well-being. Dr. Niv earned her Ph.D. in Brain and Cognitive Science from the University of Southern California, where she conducted research on EEG biomarkers, neurofeedback, and the neural underpinnings of mood and behavior. She also holds a B.A. in Molecular and Cellular Biology from UC Berkeley and an M.A. in Clinical and Cognitive Psychology from USC. Before founding Joyous, Sharon worked on developing virtual-reality interventions for chronic pain and neurofeedback programs designed to help people improve emotional regulation and resilience. A long-time meditation practitioner, she combines scientific rigor with a deep understanding of mindfulness and experiential learning. Through Joyous, Sharon and her team are pioneering low-dose (psycholytic) ketamine therapy, creating safer, more sustainable pathways for individuals and therapists to experience healing and insight. Her mission is to empower both clinicians and clients with practical tools that promote neuroplasticity, compassion, and mental clarity. The Power of Therapy + Joyous Joyous Substack LinkedIn

Broadcast from KSQD, Santa Cruz on 10-09-2025: Dr. Dawn opens by addressing an emailer's question about safety of low-dose lithium for dementia prevention. She reports finding a two-year double-blind placebo-controlled trial of 61 patients with mild cognitive impairment that showed no kidney damage from therapeutic lithium doses. While low-dose lithium at 2-3 milligrams daily appears safe compared to therapeutic doses of 50-100 milligrams, she notes its calming effects may improve cognition. >/li> She discusses over-the-counter hearing aids now available without prescription, ranging from $98 to $999, representing significant savings compared to prescription models costing four times as much. >/li> An emailer asks about long-term methotrexate use for psoriasis, reporting declining white blood cell counts and slower healing. Dr. Dawn reviews studies showing that in 13-year rheumatoid arthritis trials, severe side effects occurred in only 3% of patients. She recommends monthly blood monitoring including comprehensive metabolic panels to check liver and kidney function. As an alternative, she suggests apremilast, which showed excellent long-term safety in pooled data from half a million patient years with virtually no liver, kidney, or blood count problems. She also recommends trying phototherapy with tuned red light frequencies and topical treatments before considering drugs like etanercept that carry leukemia and lymphoma risks. >/li> Dr. Dawn expands on ultra-processed food dangers, explaining how mechanical processing of carbohydrates accelerates digestion and causes blood sugar spikes that lead to insulin resistance. Steel-cut oatmeal and wheat berries digest slowly and accelerate glucose at a low rate, while instant oatmeal and white bread hit like loud spikes. She emphasizes that processing primarily affects carbohydrates, not proteins or fats. Whole fruits are vastly superior to juices because juicing makes fruit sugars unnaturally available to metabolism. She also warns about hidden microplastics entering food through processing equipment, transport tanks, and packaging, with longer processing and travel distances increasing contamination. >/li> Dr.Dawn discusses the health dangers of sedentary behavior, noting that simply walking 20 minutes daily can lower blood pressure without requiring intense exertion. Dr. Dawn offers creative exercise solutions including bouncing on inflatable exercise balls during screen time, keeping weights in bathrooms for tooth-brushing workouts or in other frequently used spaces, doing resistance band exercises while waiting in cars, and practicing single-leg squats for balance. She describes the geriatric "get up and go" test where inability to stand, walk 10 feet, return, and sit within 10 seconds predicts five-year mortality. >/li> A caller discusses motivation challenges with his unused NordicTrack equipment. Dr. Dawn suggests making exercise rewarding by listening to engaging podcasts exclusively during workouts, creating positive associations that build sustainable habits. She explains that five minutes daily for six days weekly, maintained for a month, typically becomes permanent. The caller correctly notes that exercise increases mitochondrial production, and Dr. Dawn expands on this, explaining how oxygen debt triggers DNA signals to build new muscle fibers and mitochondria, raising metabolic rate, improving glucose metabolism, and increasing brain-derived neurotrophic factor that promotes new neural connections, making exercise crucial for preventing cognitive decline. >/li>

IANR 2535 083025 Line Up4-6pm INTERVIEWS (Gautam Sinha guest hosts for Sanchali)Here's the guest line-up for Sat, August 30, 2025 from 4 to 6pm CST on Indo American News Radio, a production of Indo American News (www.IndoAmerican-News.com). Weare on 98.7 FM and you can also listen on the masalaradio app.By Monday, hear the recorded show on Podcast uploaded on Spotify, Apple Podcasts, Pocket Casts, Radio Public and Breaker. Our Podcast has been rated #2 among 100 Podcasts in Houston by feedspot.com. We have 6 years of Podcasts and have had thousands of hits.TO SUPPORT THE SHOW, SELECT FOLLOW ON OUR FREE PODCAST CHANNEL AND YOU'LL BE NOTIFIED OF NEW UPDATES.4:20 pm A truly remarkable event will be taking place this weekend at the ISKCON temple on Ella Blvd. It is  theannual Kirtan Fest dedicated to bringing together people from all walks of life to experience the transformative power of kirtan (congregational chanting). The centerpiece of Kirtan Fest is the Pushpa Abhishek, a flower festival in which more than 30,000 Ecuadorian roses — the largest and most vibrant in the world — will transform the space into a sea of petals, color, and joy. Devotee Ananjay Raju joins us today to tell us more about the festival.4:50 pm The Jaipur Literature Festival will return to Houston next weekend, September 5 through 7 and will be held at four venues across the city, featuring many literary figures - like Houstonian Chitra Divakaruni, Sunanada Vashisht, film maker Shekhar Kapur, Amish, Ragini Tharoor Srivasan, Pria Ahmed, Sanjay Devarajan and many others - and panel discussions. Writer and poet Chitra Divakaruni will callin to talk about the significance of the Festival which will conclude on Sunday, September 7.5:20 pm Dr. Sanjay Mehta has been treating cancers of the prostate, breast, lung, brain, GI tract with focused radiation beams with minimal side effects, because it avoids collateral damage to other nearby organs. His practice has adopted the European techniques of using very low dose radiationto treat arthritis and tendonitis with excellent results in only 6 painless treatments. He joins us today – along with his dad Dr Chandra Mehta who has benefitted from this treatment - to tell us more about this promising treatment.Also stay tuned in for news roundup, views, sports and movie reviews.      TO BE FEATURED ON THE SHOW, OR TO ADVERTISE, PLEASE CONTACT US AT 713-789-NEWS or 6397 or at indoamericannews@yahoo.comPlease pick up the print edition of Indo American News which is the ONLY community paper widely available all across town at grocery stores from Hillcroft to Sugar Land, Katy and FM 1960. Also visit our website indoamerican-news.com which gets 90,000+ hits to track all current stories.And remember to visit our digital archives from over 17 years. Plus, our entire 44 years of hard copy archives are available in the Fondren Library at Rice University.

Thoracic radiologists Jeffrey Kanne, Miranda Siemienowicz and Jonathan Chung discuss the current global status of lung cancer screening, offering tips and tricks for reading these studies. Meanwhile, Andrew and Frank talk about everything BUT pulmonary nodules: another shameful journal travesty, TB sniffer rats and ketamine epiphanies.   Lung cancer screening article ► https://radiopaedia.org/articles/lung-cancer-screening Retraction Watch - Tin Man Syndrome ► https://retractionwatch.com/2025/08/15/tin-man-syndrome-case-plagiarized-from-hoax-sleuths-say/ Those TB detecting rats ► https://apopo.org/what-we-do/detecting-tuberculosis Become a supporter ► https://radiopaedia.org/supporters Get an All-Access Pass ► https://radiopaedia.org/courses/all-access-course-pass Radiopaedia Community chat ► http://radiopaedia.org/chat Ideas and Feedback ► podcast@radiopaedia.org   The Reading Room is a radiology podcast intended primarily for radiologists, radiology registrars and residents. 

Low Dose is a specially-curated segment that combines the most interesting RHJ stories into one, bite-sized episode. Bypass all the fluff and get straight to the information you need to know. This week, we highlight the scientifically-backed strategies for manifesting your dream life, how the fashion industry is poisoning you, and a very real future where parents can design their own perfect baby. You can find more information about our guests and where to find each full episode below: 00:00-03:55 - The science to manifesting your dream life (Manifestation: Dr. James R. Doty ⁠⁠https://radiohealthjournal.org/manifestation-the-scientific-path-to-creating-your-dream-life/) 04:00-07:00 - How your clothes are poisoning you (Toxic Fashion: Alden Wicker ⁠https://radiohealthjournal.org/mercury-hats-arsenic-dresses-and-poisoned-shoes-toxic-fashion/) 07:00-10:00 - The future of genetically-modified humans. (Gene Editing: Dr. Elizabeth McNally https://radiohealthjournal.org/genomics-pt-2-designer-babies-illegal-experiments-and-moral-issues/) Learn more about your ad choices. Visit megaphone.fm/adchoices

In this powerful episode of the TIck Boot Camp Podcast, Dr. Jaquel Patterson, nationally recognized naturopathic physician and medical director of Fairfield Family Health, joins Matt Sabatello to explore the many layers of Lyme disease recovery – from hidden mold exposure to hormone balance and mental health support. Mold & Lyme Disease – Why mold toxicity can block Lyme recovery and how Dr. Patterson stages treatment so patients don't get overwhelmed. Hormone Health – The vital role hormones play in energy, mood, joint health, and the ability to fight chronic infections. Mental Health & Lyme – How inflammation impacts the brain, leading to panic attacks, anxiety, depression, and brain fog — and how those symptoms can reverse with healing. Low Dose Immunotherapy (LDI) – What it is, how it retrains the immune system to stop overreacting, and why it's helping Lyme patients stabilize. Inflammation & Flares – Practical tools like turmeric, hydration, and electrolytes to calm Herxheimer reactions and ease painful flare days. Environmental Toxins – How pesticides, polluted air, and contaminated water add to the burden — and realistic steps to reduce exposure.

Ponce de León never found the Fountain of Youth. Andras Bilkei-Gorzo from the University of Bonn in Germany thinks Ponce should have looked at low dose THC. Andras and his team have been giving mice low dose THC and finding some interesting results. Listen to how to get an older mouse to swim to an invisible platform faster, how THC can flip a metabolic switch called mTOR on and off at the same time, and why low dose THC might be better for older people than younger ones. Bidirectional Effect of Long-Term Δ9-Tetrahydrocannabinol Treatment on mTOR Activity and Metabolome- paperA chronic low dose of ∆9-tetrahydrocannabinol (THC)restores cognitive function in old mice- abstractAndras Bilkei-Gorzo - LinkedInTranscripts, papers and so much more at: reefermed.ca

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Low-Dose Combinations With 3 or 4 Blood Pressure–Lowering Medications for the Treatment of Hypertension.

FMF YouTube: https://www.youtube.com/@funmedFMI Center for Optimal HealthWebsite: fmioptimal.comInstagram: @fmioptimalFunctional Medicine of Idaho:Website: funmedidaho.comInstagram: @funmedidahoWe provide the highest quality supplements with responsible sourcing and the utmost commitment to purity funmedshop.com + more resources on IG: @funmedfoundations

In this episode I'm interviewing a nuclear energy educator with a series of informative videos on LinkedIn. He works to address radiophobia and provides an evidence-based assessment of nuclear fission and the many polarized debates surrounding its safety.  Dr. Robert Hayes is an Associate Professor of Nuclear Engineering at North Carolina State University. He holds a joint faculty appointment with Savannah River National Laboratory and serves as an Associate Editor for the journal Radiation Physics and Chemistry.  Dr. Hayes is a licensed Professional Engineer in Nuclear Engineering, a Certified Health Physicist (CHP) through the American Board of Health Physics, and a Fellow of both the Health Physics Society (HPS) and the American Physical Society (APS). He has extensive experience in federal radiological emergency response, serving over a decade at the Waste Isolation Pilot Plant for the geological disposal of transuranic waste. Currently, Dr. Hayes is an advisor to the DOE-NNSA Advisory Committee on Nuclear Security and serves on the National Council of Examiners for Engineering and Surveying (NCEES) committee responsible for nuclear engineering licensure. In addition to his academic and research contributions, he is actively engaged in public communication on radiological risk, particularly in the realm of nuclear waste management.

Interview with Anna Shapiro, MD.

Show notes at pharmacyjoe.com/episode1026. In this episode, I’ll discuss hallucinations from low-dose ketamine use in the ICU. The post 1026: Is the Low-Dose Ketamine In the Room With Us Right Now? appeared first on Pharmacy Joe.

How much sin is too much? Is a little sin alright? Shane and Joe discuss how seemingly small sins affect our lives.Romans 6:23Help support the channel by sharing your favorite episodes with friends,family, coworkers, or your church.Reach out with kind words, encouragement, or topic requests: ⁠holyunqualified@gmail.com⁠Join us on Facebook: ⁠https://www.facebook.com/holyunqualifiedpodcast⁠Music:McCarthy by Blue Dot Sessions (www.sessions.blue)

Our bodies are exposed to about 20,000 hits of radiation from cosmic rays every second. Is that good or bad?

A recent #study from Assiut University Hospital in Egypt, published in #Oncotarget, presents a promising strategy for patients with metastatic #colorectalcancer (mCRC). The #research introduces a gentler yet effective maintenance therapy that may extend survival, enhance quality of life, and offer a more accessible treatment option for mCRC patients worldwide. The Challenge of Treating Metastatic Colorectal Cancer Colorectal cancer is one of the most common causes of cancer-related deaths worldwide. When it spreads to other parts of the body—a stage known as mCRC—it becomes much more difficult to treat. At this stage, clinicians often use strong drug combinations like FOLFOX or CAPOX, which mix chemotherapy drugs to stop cancer growth. FOLFOX combines three drugs given intravenously, while CAPOX includes two of the same drugs, with one taken as a pill. While effective, these treatments can cause serious side effects. For example, one of the main drugs, oxaliplatin, can lead to nerve damage, making it painful or difficult to use the hands and feet. Fatigue, diarrhea, and other issues are also common. Over time, these side effects may force clinicians to stop or adjust the treatment, even if it is working. That is where maintenance therapy comes in. After the cancer is controlled, clinicians often switch to a gentler treatment plan to keep it from returning. The challenge is finding a therapy that continues to work without causing too many side effects, especially in places where access to expensive or intensive treatments is limited. Full blog - https://www.oncotarget.org/2025/05/07/panitumumab-and-low-dose-capecitabine-a-promising-maintenance-therapy-for-metastatic-colorectal-cancer/ Paper DOI - https://doi.org/10.18632/oncotarget.28687 Correspondence to - Doaa A. Gamal - doaaalygamaal@gmail.com Video short - https://www.youtube.com/watch?v=wuPSS0EdK-8 Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28687 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, Panitumumab, maintenance, colorectal cancer, Capecitabine About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science). To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

BUFFALO, NY — May 7, 2025 — A new #research paper was #published in Aging (Aging-US) Volume 17, Issue 4, on April 4, 2025, titled “Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results.” A research team led by first author Mauricio Moel and corresponding author Stefanie L. Morgan from AgelessRx conducted a clinical trial to determine whether low-dose, intermittent rapamycin could safely improve healthspan in older adults. The findings suggest rapamycin may offer measurable benefits for physical function and overall well-being, reinforcing its potential as a safe intervention to support healthy aging. Aging remains the leading cause of chronic conditions such as heart disease, diabetes, and dementia. While medical advances have extended lifespan, many people still experience declining health and reduced mobility in later years. This growing gap between lifespan and healthspan has driven interest in therapies that target aging itself. Rapamycin, an FDA-approved drug originally used in transplant medicine, has drawn attention for its ability to influence aging-related pathways in animal studies. Until recently, its safety and benefits in healthy human populations were largely unknown. The PEARL trial is the longest study so far to explore rapamycin's use for longevity in healthy aging adults. Researchers followed 114 participants aged 50 to 85 over 48 weeks in a randomized, double-blind, placebo-controlled design. Participants received either a placebo or 5 mg or 10 mg of compounded rapamycin once per week. The study's primary goal was to measure changes in visceral fat, while secondary outcomes included lean muscle mass, blood markers, and quality-of-life assessments. The trial found that low-dose rapamycin was safe and well-tolerated, with serious side effects reported at similar rates across all groups. The most frequent minor issue among rapamycin users was mild gastrointestinal discomfort. While no significant reductions in visceral fat were observed, women taking 10 mg of rapamycin showed significant gains in lean muscle and reported reduced pain. In addition, participants taking 5 mg weekly reported improvements in emotional well-being and general health, as measured by validated surveys. “Our findings provide evidence that these rapamycin regimens are well tolerated with minimal adverse effects when administered for at least one year within normative aging individuals.” Researchers noted some limitations, including the relatively small and health-conscious participant group, which may have limited the ability to detect larger effects. The compounded form of rapamycin used also had lower absorption than commercial versions, possibly reducing its impact. Overall, the PEARL trial provides early clinical evidence that low-dose rapamycin may help support physical and emotional well-being in older adults. Further studies with larger and more diverse populations will be essential to confirm the study results and refine dosing strategies for broader application. DOI: https://doi.org/10.18632/aging.206235 Corresponding author: Stefanie L. Morgan – stefanie@agelessrx.com Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts Keywords: rapamycin, aging, healthspan, longevity, geroscience To learn more about the journal, please visit our website at https://www.Aging-US.com​​ and connect with us on social media at: Facebook - https://www.facebook.com/AgingUS/ X - https://twitter.com/AgingJrnl Instagram - https://www.instagram.com/agingjrnl/ YouTube - https://www.youtube.com/@AgingJournal LinkedIn - https://www.linkedin.com/company/aging/ Bluesky - https://bsky.app/profile/aging-us.bsky.social Pinterest - https://www.pinterest.com/AgingUS/ Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

In episode 59 we discuss outpatient low-dose initiation of buprenorphine. Suen LW, Chiang AY, Jones BLH, Soran CS, Geier M, Snyder HR, Neuhaus J, Myers JJ, Knight KR, Bazazi AR, Coffin PO.Outpatient Low-Dose Initiation of Buprenorphine for People Using Fentanyl. JAMA Netw Open. 2025 Jan 2;8(1):e2456253. We also discuss impulse control dysregulation from ropinerole, and the new non-opioid painkiller, suzetrigine. BBC:Prescription medication made me a gambling addict Grall-Bronnec M, et al.Dopamine agonists and impulse control disorders: a complex association. Drug Saf. 2018;41(1):19-75. FDA:FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain Vertex Pharmaceuticals: Randomized, Placebo-Controlled, Phase 3 Trials of Suzetrigine, a Non-Opioid, Pain Signal Inhibitor for Treatment of Acute Pain After Abdominoplasty or Bunionectomy --- This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go tothis link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visitMI CARES. CME:https://micaresed.org/courses/podcast-addiction-medicine-journal-club/ --- Original theme music:composed and performed by Benjamin Kennedy Audio editing: Michael Bonanno Executive producer:Dr. Patrick Beeman A podcast fromArs Longa Media --- Learn more about your ad choices. Visit megaphone.fm/adchoices

DNS Podcast Dave Crosland & Scott McNally 0:00 teaser 0:30 Intro and advertisers 1:45 Lots of Yawns today 2:20 Will Tariffs Impact Gear? 7:20 what sources are saying 16:25 Varying opinions on Low Dose 19:00 Have cycle expectations changed? 23:20 Should we block DHT on cycle? 28:15 Synthoil Comment 29:45 How long on TRT between blasts 33:00 Tips to break a Plateau 42:50 No Changes in weight or strength on anadrol? 45:30 Do we count ester weight when designing a cycle 49:30 l-carnatine and improved sperm 53:45 High Estrogen and Acne 57:30 Uncle Dave's Wisdom 1:03:15 Uncle Dave's Wisdom Bonus 1:06:00 Dave's App (linked below)

In this solo episode, I'm breaking down one of the most talked-about tools in the health optimization world right now—peptides. From healing faster to building lean muscle, improving fat loss, enhancing sleep, and even slowing down the aging process… peptides are powerful. But they're also misunderstood, under-regulated, and often misused. So in this episode, I'm walking you through exactly what peptides are, how they work, the most popular ones in each category, and both the pros and cons of using them. This is a no-BS, educational breakdown of everything you need to know before exploring peptides as a tool for better health, performance, or aesthetics. I also cover some legal and sourcing realities—because here's the truth: most peptides aren't FDA-approved, and you'll only find them labeled for “research purposes only.” This isn't an endorsement. It's a breakdown to help you make smarter, more informed decisions.   What I Cover in This Episode: What peptides are and how they're different from hormones or steroids Legal disclaimers and how they're commonly sourced Growth hormone peptides: CJC-1295, Ipamorelin, MK-677 Fat loss peptides: AOD 9604 and Tesamorelin Healing peptides: BPC-157 and TB-500 Anti-aging + cognitive peptides: GHK-Cu (Copper peptide), Epitalon, Semax, Selank Mitochondrial optimizer: MOTS-c and why it's a game-changer for metabolic health How to stack peptides and what to avoid Side effects, risks, and what to consider before diving in   Links & References: Biological Activities and Safety of Citrus spp. Essential Oils - Click Here Essential role of TRPC6 channels in G2/M phase transition and development of human glioma - Click Here   Final Take: Peptides can be a powerful tool—but they're not a magic bullet. If you're training hard, eating right, sleeping well, and want to push to the next level, they might offer that extra edge. Just make sure you're doing it smart, and not chasing shortcuts.   Register For 30-Strong - Register Here   Join The Collective - Join Here   Interested in working with a coach? Get a free nutrition consultation - Schedule Here   Join Us On Patreon - Join Here   Submit your questions to be featured on our Q&A episodes.   Order from Cured Supplement Order from Legion Supplements and get 20% off your first order by using discount code: keynutrition   Connect with us on Instagram Host Brad Jensen – @thesoberbodybuilder Next Level Nutrition – @mynextlevelnutrition   Episode Timestamps 00:00 "Peptides: Unapproved but Legally Sold" 04:38 Compounding vs. Big Pharma Conflict 07:44 Benefits of Growth Hormone 13:31 MK677's Effects on Body Composition 16:51 Water Retention from Low Dose? 18:30 Health Supplement: Benefits and Considerations 23:35 "GLP1s and Peptide Therapy Debate" 27:03 GHK-CU: Skin and Anti-Aging Benefits 28:14 Copper Peptides for Hair and Healing 32:39 Growth Hormones and Water Retention 34:41 Success with BPC and TB500 40:13 GLP1s Fat Loss: Efficacy Concerns 42:03 "Peptides vs. Steroids: Health Debate" 45:11 "Join the Daily Wellness Movement"

Whats the lowest effective dose of tren? Well, We are going to find out lol. Plus my experinece loading carbs on GLP-1 meds like retatrutide or semaglutide. DADA = Massive Endurance PLUS your listner questions! ✅ Coach Scott McNally hangs with you guys and talks shop. Reach out for coaching or show sponorship at : mcnallydiets@gmail.com

Today was a fun show that we just got done recording. If you’re interested make sure to visit Kate’s new website. She’s blogging on there quite often.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Sanjay Mehta is a radiation oncologist with over 25 years of experience, and is currently the president of Century Cancer Centers in Houston, Texas (drsanjaymehta.com). In this episode, Sanjay explores the rapidly evolving field of radiation oncology, addressing common misconceptions about radiation exposure. He delves into radiation's critical role in modern oncology, examining recent advancements that precisely target tumors while minimizing damage to surrounding healthy tissues and reducing side effects, with specific insights into breast, prostate, and brain cancers. Sanjay discusses fascinating international practices involving low-dose radiation therapy for inflammatory conditions such as arthritis, tendonitis, and sports injuries, highlighting its effectiveness and potential for wider adoption in the United States. Wrapping up on a lighter note, Peter and Sanjay discuss their mutual passion for cars and reveal how this shared interest first brought them together. We discuss: How radiation oncology became a distinct, rapidly evolving medical specialty [2:45]; Defining radiation, ionizing vs. non-ionizing, and common misconceptions about radiation exposure [5:30]; How radiation doses are measured, real-world examples of radiation exposure, and safety practices [9:00]; Radiation doses from common medical imaging tests, and why benefits of routine imaging outweigh risks [14:15]; Therapeutic radiation oncology: the evolution of breast cancer treatment toward less invasive surgery combined with targeted radiation [23:30]; Modern radiation oncology treatments for breast cancer—minimizing risks and maximizing patient comfort and outcomes [27:15]; How advances in radiation dosing, technology, and treatment precision have significantly reduced side effects [39:45]; How breast implants affect radiation treatment [44:45]; Radiation therapy for prostate cancer: advancements in precision, effectiveness, and patient selection criteria [48:00]; Radiation therapy options for inoperable prostate cancer or those seeking alternatives to surgery, and a remarkable patient case study [55:15]; How patients can effectively evaluate and select a high-quality radiation oncologist [1:05:45]; Radiation therapy for brain cancer: the shift toward precise, targeted techniques that minimize cognitive side effects, and remaining challenges [1:08:30]; The origins of radiophobia and how it influenced perceptions of radiation use in medicine [1:18:00]; Treating chronic inflammatory conditions such as tendinitis, arthritis, and more with very low-dose radiation [1:23:45]; Using low-dose radiation to treat spine injuries, scar tissue, fibrosis, keloids, and more [1:30:00]; The current barriers preventing widespread adoption of low-dose radiation therapy for inflammatory conditions [1:35:45]; The durability and versatility of low-dose radiation therapy in treating chronic inflammatory and arthritic conditions [1:40:45]; Sanjay's talent as a drummer [1:44:45]; Peter and Sanjay's shared passion for cars and racing [1:47:15]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

DNS Podcast 261 Dave Crosland & Scott McNally 00:00 Detroit Pro Recap and Competitor Insights 05:41 Exploring Low Dose Steroid Cycles 22:04 Listener Questions and Personal Experiences 27:20 The Evolution of Anabolic Steroids 31:12 Anadrol and Cutting Cycles 35:30 Navigating the End of the World: An Effort Stack 40:17 Sperm Quality and Testosterone Therapy 45:22 Aromatase Inhibitors: When to Stop? 50:04 Stress Management and Productivity ✅ Amino Asylum code THINK for 20% off research chems, peptides, l-carnitine and more https://aminoasylum.shop/ref/122/ ✅ Parabolic Peptides Code THINK for 10% off SLU, Research Chems, Peptides & more https://parabolicpeptides.com

Have you ever wondered what being high actually feels like, especially with low-dose cannabis? In this episode, Ellen and innovation & strategy expert Nicole Brown break down the future of socializing with cannabis, alcohol, and non-alcoholic drinks. If you've ever wished for a more predictable, enjoyable, and easy-to-access cannabis experience, this episode will get you excited about what's next. Nicole shares:  Why she believes we're living in Cannabis 2.0 How access to hemp-derived products is changing the game What she tells her friends who are curious about trying low-dose THC. If you enjoyed this episode, we recommend Episode 274. If You Like Chardonnay, Try A Weed Drink, Part 3 Hosted by Ellen Scanlon Sign up for Ellen's newsletter on Substack at https://dothepot.substack.com/ or at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠dothepot.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Thank you for supporting our sponsor! Try Potli's Dream Good Night Chews, and use code DOTHEPOT for 20% off Follow on IG: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@dothepot⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / FB: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@dothepot⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / X: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@dothepot⁠⁠⁠

We are delighted to partner with Western Radiation Oncology today, with two of their distinguished radiation oncologists joining us on the Prostate Health Podcast.  LDR (Low Dose Rate) prostate brachytherapy has recently been an underutilized treatment for prostate cancer. However, advancements in modern techniques have demonstrated that LDR brachytherapy, a procedure that can be performed quite easily in an ambulatory surgery center, offers high cure rates with minimal long-term complications, making it a convenient, non-invasive option for men with prostate cancer. Today, we chat with Dr. Steven Kurtzman and Dr. Ankit Agarwal, two distinguished radiation oncologists working to expand access to LDR brachytherapy by partnering with urologists to establish new programs across the United States.  Drs. Kurtzman and Agarwal are national leaders in targeted real-time intraoperative planned brachytherapy. With over 7,000 implants performed in the past two decades and more than 700 procedures conducted annually, they have managed to preserve this specialized technique despite its limited expansion in recent years. Based primarily in the Bay Area, California, they provide exceptional cancer care while collaborating with urologists, medical oncologists, and prostate cancer specialists across the United States to assist in establishing LDR programs in ambulatory surgery centers nationwide to provide high-quality prostate cancer care. Tune in to learn more about this promising treatment option! Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation. Show Highlights: Who are the most viable candidates for LDR brachytherapy? How the treatments for low, intermediate, and high-risk prostate cancer patients differ The benefits of a combination of brachytherapy and external beam radiation for high-risk prostate cancer patients How factors like urinary function, bowel function, and prostate size can influence men's eligibility for LDR brachytherapy Why prostate size is no longer a limitation for brachytherapy treatment How is the LDR brachytherapy procedure performed? What can patients expect in terms of recovery and side effects following brachytherapy? Post-therapy safety precautions Links:  Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd  Get your free What To Expect Guide (or find the link on our podcast website)   Join our Facebook group  Follow Dr. Pohlman on Twitter and Instagram  Go to the Prostate Health Academy to sign up.  You can access Dr. Pohlman's free mini webinar, where he discusses his top three tips to promote men's prostate health, longevity, and quality of life here. Sponsor Links:  Western Radiation Oncology Brachytherapy for Prostate Cancer with Dr. Steven Kurtzman and Dr. Ankit Agarwal on YouTube Expanding Treatment Options at Ambulatory Surgical Centers: LDR Brachytherapy for Prostate Cancer    

Dr. Dustin Jones // #GeriOnICE // www.ptonice.com  In today's episode of the PT on ICE Daily Show, join Modern Management of the Older Adult division leader Dustin Jones discusses the concept of "stronger with less," focusing on low dose training for older adults. He highlights a recent publication that challenges traditional biases regarding the dosage needed to elicit a positive response in older adults. Dustin aims to provide hope and practical insights for healthcare professionals, particularly those with limited interaction time with patients. He emphasizes the gap between recommended physical activity guidelines—such as 150 minutes of vigorous activity or 300 minutes of moderate activity weekly, along with resistance training—and the reality that many older adults, as well as healthcare providers, struggle to meet these standards. Dustin addresses the tension that arises when considering effective interventions that may fall short of conventional expectations, particularly in settings like home health and skilled nursing facilities. Take a listen to learn how to better serve this population of patients & athletes, or check out the full show notes on our blog at www.ptonice.com/blog. If you're looking to learn more about live courses designed to better serve older adults in physical therapy or our online physical therapy courses, check our entire list of continuing education courses for physical therapy including our physical therapy certifications by checking out our website. Don't forget about all of our FREE eBooks, prebuilt workshops, free CEUs, and other physical therapy continuing education on our Resources tab.

Show notes at pharmacyjoe.com/episode1002. In this episode, I’ll discuss some possible negative effects of using low-dose ketamine to achieve an opioid-sparing effect in critically ill patients. The post 1002: Less Opioid Consumption With Low-Dose Ketamine But at What Cost? appeared first on Pharmacy Joe.

BUFFALO, NY - February 18, 2025 – A new #researchpaper was #published in Oncotarget, Volume 16, on February 12, 2025, titled “Could Panitumumab with very low dose Capecitabine be an option as a maintenance regimen." In this study, researchers Doaa A. Gamal, Aiat Morsy, and Mervat Omar from Assiut University Hospital, evaluated a new maintenance treatment for metastatic colorectal cancer (mCRC). Their findings suggest that a combination of two drugs—Panitumumab, a targeted therapy that blocks a protein called epidermal growth factor receptor to slow cancer growth, and low-dose Capecitabine, a chemotherapy drug that converts into 5-fluorouracil (5-FU) inside the body to stop cancer cells from growing and dividing—could help extend survival in patients with mCRC. This regimen appears to be both effective and well-tolerated, especially for patients with wild-type KRAS mCRC who had previously responded to treatment. Colorectal cancer is one of the leading causes of cancer-related deaths worldwide. Standard treatment often involves a combination of chemotherapy and targeted therapies, but many patients face challenges related to treatment toxicity and resistance, which can lead to treatment interruptions. This study tested whether a lower-intensity maintenance treatment could help keep the cancer under control after initial treatment. The study involved 25 mCRC patients with wild-type KRAS and BRAF, who first received six rounds of standard 5-FU-based chemotherapy with Panitumumab. Patients who responded well then switched to a maintenance treatment of Panitumumab every two weeks and a low, continuous dose of Capecitabine. The results showed that patients had a median progression-free survival of 18 months and a median overall survival of 45 months, indicating a strong potential benefit. Patients with metastases detected at the same time as the primary tumor showed a longer progression-free survival than those with metastases appearing later. The treatment was also well tolerated, with only 8% of patients experiencing severe side effects such as skin rash or diarrhea, which were managed with standard treatments. "In our research, the toxicity profile was very acceptable, and no patients needed to stop treatment or had a dose modification due to toxicity." Finding a way to keep cancer under control while reducing side effects is a major goal in cancer treatment. While other maintenance therapies like Bevacizumab and Cetuximab have been studied, this research suggests that Panitumumab with low-dose Capecitabine could be a promising new option. Panitumumab is already an FDA-approved drug, but its role in maintenance therapy had not been extensively explored. The results of this study suggest that this combination may help delay disease progression while keeping side effects manageable, ultimately improving patients' quality of life. Although larger studies are needed, these findings open the door for further clinical trials to confirm the benefits of this regimen. If validated, this approach could change the standard of care for mCRC patients, particularly those who cannot tolerate more intensive chemotherapy. DOI - https://doi.org/10.18632/oncotarget.28687 Correspondence to - Doaa A. Gamal - doaaalygamaal@gmail.com Video short - https://www.youtube.com/watch?v=wuPSS0EdK-8 To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

In this podcast, Dr. Valentin Fuster discusses the Target for NA trial, which compares biodegradable polymer stents to second-generation drug-eluting stents for coronary intervention. While the results showed the biodegradable stents were non-inferior in preventing target lesion failure, questions remain regarding their real-world performance and procedural handling in clinical practice.

Outpatient Low-Dose Initiation of Buprenorphine for People Using Fentanyl JAMA Network Open The accumulation of fentanyl in fat is likely responsible for the risk of precipitated withdrawal when buprenorphine is initiated. Low dose initiation (LDI) of buprenorphine attempts to minimize this risk. This retrospective study included 126 individuals making 175 LDI attempts in an outpatient setting. Patients chose either a 4 day or 7 day LDI protocol with buprenorphine monoproduct. Both protocols begin with buprenorphine 0.5mg, increasing to 8mg tid. Overall LDI was successful in 34% of attempts (with no difference between the protocols) and one month retention on buprenorphine was 21%. Repeated LDI attempts were less likely to be successful (second attempt aOR 0.3). Unhoused people had lower odds of success (OR 0.4). The authors conclude that people with OUD using fentanyl attempting outpatient LDI of buprenorphine had low odds of success.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

Experts have warned of alarming risks of the popular painkiller, ibuprofen. The common over-the-counter medication is used by millions of Americans to alleviate pain and reduce inflammation, for instance in arthritis. Special Guest: Nick Stern, CEO & Founder of Sun Nutrition at www.sunnutrition.com

Low-dose ketamine as an adjunct to morphine: A randomized controlled trial among patients with and without current opioid use by SAEM

Low-dose ketamine as an adjunct to morphine: A randomized controlled trial among patients with and without current opioid use by SAEM

On this episode of The Vitamin Professor Podcast, Professor Gene Bruno speaks with Dr. Robert Nash, PhD of IminoTech Inc. This podcast is brought to you in partnership with VRM Media and Nutraland USA, Inc. For more information about our host and guest, please see the below information. iminotech.com https://www.linkedin.com/in/robert-nash-737a4918/ https://nutralandusa.com https://linkedin.com/in/gene-bruno-ms-mhs-rh-ahg-2ab0508 https://vrmmedia.com @hnvirtual, #hnvirtual, #genebruno, #thevitaminprofessor Find our podcast on your favorite platform: podcasts.apple.com/us/podcast/the-vitamin-professor-podcast/id1746137375 youtube.com/channel/UCxeQ-IuqCRmq0YLc7jQNMKA music.amazon.com/podcasts/a8a96593-b93c-48cf-9fe9-2891c4035dad/the-vitamin-professor-podcast iheart.com/podcast/269-the-vitamin-professor-podc-175888136/

As 2024 comes to an end, I'm rounding up some of the best gut health research and advice from the past year! In this compilation video, I'll share some of the best gut supplement recommendations as given by great expert guests – Dr. Allison Siebecker, Herbalist Olivia Amitrano, Dr. Alex Ford, Dr. Josh Axe, and Nutritional Therapist Elliot Overton. You don't want to miss this! Watch full interviews with each expert below.  

In this podcast, Dr. Valentin Fuster discusses a groundbreaking study on the efficacy and safety of a novel low-dose triple combination pill for the initial treatment of hypertension. The study highlights how a single pill containing three blood pressure-lowering agents can significantly reduce blood pressure while improving patient adherence, offering a promising solution for hypertension management globally, especially in low-income settings.

Author Robert W. Yeh, MD, FACC, and JACC Associate Editor Celina M. Yong, MD, FACC, discuss the results of the TARGET-IV NA trial. In the trial, 1720 patients with stable or acute coronary syndromes were randomized to undergo PCI with a BP-SES or any commonly used 2nd generation DES. At 12 months, BP-SES was non-inferior to control DES for the primary endpoint of Target Lesion Failure (cardiac death, target vessel-related myocardial infarction (MI), or ischemia-driven target lesion revascularization) which occurred in 3.4% of the BP-SES arm versus 3.3% in the control arm; p-value for non-inferiority. Secondary endpoints were also similar between groups.

Lung cancer remains the leading cause of cancer-related deaths world-wide it's also among the deadliest of cancers because it's caught late stage. Learn if you qualify for a low dose CT screening and how to get one.

Welcome back to our weekend Cabral HouseCall shows! This is where we answer our community's wellness, weight loss, and anti-aging questions to help people get back on track! Check out today's questions:    Stacey: Hi Dr.Cabral , what is your opinion on low dose Ketamine? I know you spoke of it briefly a year or so ago but on not daily low dose, and at that time you were still researching between Ketamine and Psilocybin. What have your findings been ? I'm considering trying low dose ketamine for SEVERE Sensory overload, anxiety & now depression because it's robbing my life . I've been working on root cause , doing protocols, detoxes ect and have improved a lot but that just won't leave and by far the most worst of my symptoms. I tried SSRIs and my body does not like them at all , on Xanax now just to barely function and refuse to go up in dose per my Dr. wanting me to increase dose to help . Hoping your research can help my decision. I'm in CA and I don't think psilocybin is legal here yet .   Audrey: Hi Dr. Cabral, I try to avoid plastics whenever possible but sometimes they are hard to avoid. What about local honey at the farmers market that comes in a plastic bottle? Or drinking chilled water out of a plastic insulated thermos? I know leaching is terrible when the plastic is heated, but curious if the plastic doesn't get hot if it is just as bad. thanks   Anonymous: I tested positive for an STD called Ureaplasma, which is know to cause PID and infertility. I've taken many rounds of antibiotics and it has not gone away. I am also experiencing mild symptoms of urethritis which this is known to cause. I was wondering if there is any natural treatment for STDs or urethritis. I am also wondering if taking biofilms with the next round of antibiotics could help the antibiotics work better?   Sara: Hi Dr. Cabral, I just read your article on alkalized water and was wondering if there is whole home filter you would recommend. I have a small filter under my house and need to replace it. I looked at the AquaTru under sink filter, which looks great, but is there a good option to have a whole house alkalized filter? Thanks! Sara   Cindy: First , thank you for your generosity in sharing your knowledge so freely! I'm always looking for safe alternatives for anti-aging/beauty products in lieu of injectables, etc. Are you familiar with Procell? Procell uses microchanning along with a topically applied serum. According to their website “Procell's Microchannel Delivery Serum contains bone marrow-derived growth factors in a hyaluronic acid suspension. Both of these elements are naturally-occurring in the human body. There are no human, animal, or plant cells, DNA, blood, or any other foreign substances. The product has been used safely and effectively for over a decade.” How does one determine the safety of a product like this? I value your opinion! Is Procell therapy safe? Is microchanneling safe?   Thank you for tuning into today's Cabral HouseCall and be sure to check back tomorrow where we answer more of our community's questions!    - - - Show Notes and Resources: StephenCabral.com/3179 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!  

Watch Here : https://www.youtube.com/watch?v=7XO6UkoJTTo Website: https://vigoroussteve.com/ Consultations: https://vigoroussteve.com/consultations/ eBooks: https://vigoroussteve.com/shop/ YouTube Channel: http://www.youtube.com/user/VigorousSteve/ Workout Clips Channel: https://www.youtube.com/channel/UCWi2zZJwmQ6Mqg92FW2JbiA Instagram: https://instagram.com/vigoroussteve/ TikTok: https://www.tiktok.com/@vigoroussteve Reddit: https://www.reddit.com/r/VigorousSteve/ PodBean: https://vigoroussteve.podbean.com/ Spotify: https://open.spotify.com/show/2wR0XWY00qLq9K7tlvJ000 Patreon: https://www.patreon.com/vigoroussteve

Send us a Text Message.Effect of Low-Dose Iron Supplementation on Early Development in Breastfed Infants: A Randomized Clinical Trial.Svensson L, Chmielewski G, Czyzewska E, Domellöf M, Konarska Z, Piescik-Lech M, Späth C, Szajewska H, Chmielewska A.JAMA Pediatr. 2024 Jul 1;178(7):649-656. doi: 10.1001/jamapediatrics.2024.1095.PMID: 38739382 Clinical Trial.As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Severe pulmonary infections are a leading cause of death in adults worldwide. Romain Pirracchio, MD, MPH, PhD, of the University of California-San Francisco, joins JAMA Deputy Editor Kristin L. Walter, MD, MS, to discuss Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections. Related Content: Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections

Show notes at pharmacyjoe.com/episode929. In this episode, I'll discuss the incidence of torsades from low-dose ondansetron in peri-operative patients. The post 929: What is the incidence of torsades from low-dose ondansetron in peri-operative patients? appeared first on Pharmacy Joe.

Hey its Chalene Johnson, and today I'm chatting with Dr. Tyna Moore about the unconventional uses of semaglutide aka GLP 1 Agonists, Ozempic, Wegovy, Mounjaro,  and Tirzepatide for treating cognitive decline, arthritis, brain fog, hormonal weight loss and more. Learn about weight loss peptides, low dosing and microdosing, minimizing side effects, and the importance of preserving muscle while using this game-changing drug. Don't miss out on this eye-opening discussion!  Watch this episode on YouTube on SUNDAY!  Learn More About Dr. Tyna Instagram: @drtyna Ozempic Uncovered Course:  Podcast: The Dr. Tyna Show Youtube (Podcast): https://youtube.com/@drtyna Website: drtyna.com Related Episodes: Ozempic and Addiction | Shocking New Research Watch Listen Berberine vs Ozempic | Natural Weight Loss Watch Listen Ozempic, Wegovy | Is Weight Loss As Simple As Eating Less? Watch Listen   Join the all-new Phase It!! A Personalized Plan to Fit Your Life

Irritable bowel syndrome (IBS) is often diagnosed when symptoms don't have an obvious cause. But anyone with IBS symptoms knows it's a REAL condition. Dr. Alex Ford and I are share what irritable bowel syndrome treatments are getting wrong—and how to start feeling better.